Reported Apr 14, 2021 · Ongoing
Guanfacine Extended-Release Tablets 2 mg,100-count bottles, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario…
Apotex Corp.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Apotex Corp. · 2400 N Commerce Pkwy Ste 400 · Weston, FL · 33326-3253
Is this the product you have?
Guanfacine Extended-Release Tablets 2 mg100-count bottlesRx Only
- Manufactured byApotex Inc. Toronto
- Ontario Canada M9L 1T9 Manufactured for
Apotex Corp. WestonFlorida 33326NDC 60505-3928-1UPC 3 60505 39281 0
- Lot codes and dates
Lot #: RX1662RX1663RX1664 Exp. 11/2022
- Amount recalled
- 55620 bottles
Where it was sold
- Nationwide
Why it was recalled
Cross Contamination with Other Product: Product is being recalled due to Trace Amounts of Quetiapine Fumarate
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Apotex Corp. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.